EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Vaccines for Chronic Viral Infections: From Immune Modulation to Clinical Translation

Zhuang Li, Yuan Zhang, Yiyang Zheng, Hongyu Wang, Chenyang Xu, Qing He

Vaccines · 04.06.2026 · 14 (6) · 507

DOI: 10.3390/vaccines14060507 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 04.06.2026. Verfasst von Zhuang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing 102629, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 246 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes for Food and Drug Control.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic vaccines are a key strategy to achieve the goal of “functional cure” of chronic viral infections, including hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), human papillomavirus (HPV), and Epstein–Barr virus (EBV). Various platforms (such as viral vectors, nucleic acid vaccines, recombinant proteins, etc.) have successfully induced strong virus-specific T-cell responses in early trials, but their clinical efficacy is still limited by the immunosuppressive environment formed by the host. The core bottlenecks are severe T-cell exhaustion, viral immune escape, and various forms of local immune tolerance. Therefore, the field is moving toward combination therapies, including reduction of viral load, targeting of immune activation, and inhibition of inhibitory signaling pathways. This article summarizes the preclinical and clinical progress of therapeutic vaccines in the past decade, analyzes the major challenges in vaccine development, and discusses the future development directions in this field.

Schlagwörter

Stichwörter der Autor:innen

Epstein–Barr virusT-cell exhaustionchronic viral infectionscombination therapyfunctional curehepatitis B virushepatitis C virushuman immunodeficiency virushuman papillomavirustherapeutic vaccines

Autor:innen und Institutionen

  • State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing 102629, China.
  • School of Biopharmacy, China Pharmaceutical University, Nanjing 211198, China.

Förderung

  • National Institutes for Food and Drug Control

Zitieren

APA

Li, Z., Zhang, Y., Zheng, Y., Wang, H., Xu, C., & He, Q. (2026). Therapeutic Vaccines for Chronic Viral Infections: From Immune Modulation to Clinical Translation. Vaccines, 14(6), 507. https://doi.org/10.3390/vaccines14060507

Vancouver

Li Z, Zhang Y, Zheng Y, Wang H, Xu C, He Q. Therapeutic Vaccines for Chronic Viral Infections: From Immune Modulation to Clinical Translation. Vaccines. 2026;14(6):507. doi:10.3390/vaccines14060507

BibTeX
@article{Li2026,
  author = {Li, Zhuang and Zhang, Yuan and Zheng, Yiyang and Wang, Hongyu and Xu, Chenyang and He, Qing},
  title = {Therapeutic Vaccines for Chronic Viral Infections: From Immune Modulation to Clinical Translation},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {6},
  pages = {507},
  doi = {10.3390/vaccines14060507}
}
Kostenlos starten →